Zobrazeno 1 - 10
of 21
pro vyhledávání: '"S. L. Lysikova"'
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 23, Iss 4, Pp 480-498 (2023)
Scientific relevance. The clinical effects and the expiration of patents for original (reference) biotechnological medicines based on monoclonal antibodies (mAbs) stimulated the development of biosimilar mAbs. The quality profile of a biosimilar mAb
Externí odkaz:
https://doaj.org/article/a238d050a1dd47959698a4419c4b9c0f
Autor:
N. А. Alpatova, Zh. I. Avdeeva, S. L. Lysikova, O. V. Golovinskaya, L. A. Gayderova, V. P. Bondarev
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 21, Iss 1, Pp 20-30 (2021)
One of the major public health challenges today is development of new vaccines and technologies to optimize the vaccination process. There is a growing scientific interest in vaccine adjuvants that enhance vaccine immunogenicity. At present, numerous
Externí odkaz:
https://doaj.org/article/c1f69a823e67430ca95ffab72cb47f36
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 20, Iss 4, Pp 245-256 (2020)
One of priority issues of the present-day healthcare system is development of new vaccines and improvement of existing ones due to decreasing immunocompetence of the population, emergence of new infections and reemergence of old ones which were previ
Externí odkaz:
https://doaj.org/article/3e75ca38bcc84ab2a217503a475ee867
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 20, Iss 1, Pp 21-29 (2020)
The review is devoted to specific aspects of the development of post-vaccination immunity following immunisation with different types of antiviral vaccines, as well as to ways of increasing immunogenicity of vaccines and effectiveness of preventive v
Externí odkaz:
https://doaj.org/article/868460d801524885a171b14115589023
Autor:
O. V. Golovinskaya, S. L. Lysikova, Yu. N. Lebedeva, N. A. Alpatova, A. A. Movsesyants, V. A. Merkulov
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 18, Iss 3, Pp 168-174 (2018)
Biotechnological products, like all other medicinal products, have to comply with efficacy, safety and quality requirements. Quality evaluation of medicines includes assessment of test methods used to control medicinal product quality (described in p
Externí odkaz:
https://doaj.org/article/a6ef257dcd054070b6f6581fe7924ae7
Autor:
N. A. Alpatova, L. A. Gayderova, A. K. Yakovlev, E. V. Motuzova, S. L. Lysikova, A. A. Soldatov, Zh. I. Avdeeva
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 17, Iss 1, Pp 13-26 (2018)
The review looks into various aspects of assessing specific activity of biotechnological products, which is one of their key quality parameters. Approaches to the analysis of this parameter and the choice of test procedures are governed by the nature
Externí odkaz:
https://doaj.org/article/1f47d98af28243328ea946bb424e01c9
Autor:
Zh. I. Avdeeva, A. A. Soldatov, N. A. Alpatova, M. V. Kiselevsky, S. L. Lysikova, V. P. Bondarev, N. V. Medunitsyn, V. D. Mosyagin, V. A. Merkulov, A. N. Mironov
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 0, Iss 1, Pp 4-14 (2018)
The article describes general principles of evidence-based quality assessment research of a recombinant granulocyte colony stimulating factor preparation (G-CSF) under development as well as a confirmation of its similarity to reference preparation (
Externí odkaz:
https://doaj.org/article/32d1b22672a74dfc8c9d6bb84302f9fe
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 0, Iss 3, Pp 4-16 (2018)
One of the most complicated issues of modern medicine is diagnosis, treatment and prevention of rare diseases. In the structure of rare diseases the vast majority accounts for genetically determined disorders. The introduction of genetic testing meth
Externí odkaz:
https://doaj.org/article/529672b09bd64b58911646911672a181
Autor:
A. A. Soldatov, Zh. I. Avdeeva, N. A. Alpatova, N. V. Medunitsyn, S. L. Lysikova, V. A. Merkulov
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 0, Iss 2, Pp 24-35 (2018)
Biological preparations differ substantially from low molecular weight chemicals in molecular weight, multidimensional structure of an active substance, presence of post-translational modifications, composition of impurities and excipients, drug manu
Externí odkaz:
https://doaj.org/article/d0ea2a65db944e148348e59e32ca767f
Publikováno v:
Voprosy pitaniia. 72(3)
At 60 patients with coronary artery disease and high blood pressure studied effects of a diet with low lipid and flavons. The application of a diet and flavons promoted positive dynamics (changes) of clinical manifestations of disease, lipid spectrum